Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 27:11:134.
doi: 10.1186/1471-2377-11-134.

Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features

Franziska Hopfner  1 , Barbara Schormair, Franziska Knauf, Achim Berthele, Thomas R Tölle, Ralf Baron, Christoph Maier, Rolf-Detlef Treede, Andreas Binder, Claudia Sommer, Christian Maihöfner, Wolfram Kunz, Friedrich Zimprich, Uwe Heemann, Arne Pfeufer, Michael Näbauer, Stefan Kääb, Barbara Nowak, Christian Gieger, Peter Lichtner, Claudia Trenkwalder, Konrad Oexle, Juliane Winkelmann
Affiliations

Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features

Franziska Hopfner et al. BMC Neurol. .

Abstract

Background: Action myoclonus-renal failure syndrome is a hereditary form of progressive myoclonus epilepsy associated with renal failure. It is considered to be an autosomal-recessive disease related to loss-of-function mutations in SCARB2. We studied a German AMRF family, additionally showing signs of demyelinating polyneuropathy and dilated cardiomyopathy. To test the hypothesis whether isolated appearance of individual AMRF syndrome features could be related to heterozygote SCARB2 mutations, we screened for SCARB2 mutations in unrelated patients showing isolated AMRF features.

Methods: In the AMRF family all exons of SCARB2 were analyzed by Sanger sequencing. The mutation screening of unrelated patients with isolated AMRF features affected by either epilepsy (n = 103, progressive myoclonus epilepsy or generalized epilepsy), demyelinating polyneuropathy (n = 103), renal failure (n = 192) or dilated cardiomyopathy (n = 85) was performed as high resolution melting curve analysis of the SCARB2 exons.

Results: A novel homozygous 1 bp deletion (c.111delC) in SCARB2 was found by sequencing three affected homozygous siblings of the affected family. A heterozygous sister showed generalized seizures and reduction of nerve conduction velocity in her legs. No mutations were found in the epilepsy, renal failure or dilated cardiomyopathy samples. In the polyneuropathy sample two individuals with demyelinating disease were found to be carriers of a SCARB2 frameshift mutation (c.666delCCTTA).

Conclusions: Our findings indicate that demyelinating polyneuropathy and dilated cardiomyopathy are part of the action myoclonus-renal failure syndrome. Moreover, they raise the possibility that in rare cases heterozygous SCARB2 mutations may be associated with PNP features.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree of the AMRF family with mutation status. Black symbol: AMRF. Grey symbol: generalized epilepsy and reduction of nerve conduction velocity in the feet. +/+: homozygous mutation, +/-: heterozygous mutation. Symbol #: no information available about genotype status.
Figure 2
Figure 2
SCARB2 sequence in the AMRF family. Top row, homozygous c.111delC mutation of patient II:3. Middle row, sequence of heterozygous carrier II:5. Bottom row, wild type sequence.
Figure 3
Figure 3
SCARB2 sequence in a PNP patient. Top row, heterozygous mutation c.666delCCTTA. Bottom row, wild type sequence.
See this image and copyright information in PMC

References

    1. Andermann E, Andermann F, Carpenter S. et al. Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology. Adv Neurol. 1986;43:87–103. - PubMed
    1. C Badhwar A, Berkovic SF, Dowling J. et al. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain. 2004;127:2173–2182. doi: 10.1093/brain/awh263. - DOI - PubMed
    1. Berkovic SF, Dibbens LM, Oshlack A. et al. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet. 2008;82:673–684. doi: 10.1016/j.ajhg.2007.12.019. - DOI - PMC - PubMed
    1. Rothdach AJ, Dietl T, Kümpfel T, Gottschalk M, Schumann EM, Trenkwalder C. Familial myoclonus-renal failure syndrome. Nervenarzt. 2001;72(8):636–640. doi: 10.1007/s001150170065. - DOI - PubMed
    1. Vega MA, Seguí-Real B, García JA. et al. Cloning, sequencing, and expression of a cDNA encoding rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36. J Biol Chem. 1991;266(25):16818–16824. - PubMed

Substances